SIGA Announces Marketing Authorization Filing for oral tecovirimat with the European Medicines Agency for Multiple Indications
– Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications –NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — SIGA […]